Eaitai Health will issue shares to raise approximately HK$915 million.

Everbright Medical announced on the Hong Kong Stock Exchange that it has agreed to sell around 35 million shares at a price of 26 Hong Kong dollars per share. The placement price represents a discount of approximately 16% from the closing price on Wednesday. The placement shares will account for about 17% of the enlarged issued shares. The company aims to raise approximately 915 million Hong Kong dollars through this placement, with the proceeds being used to expand its product portfolio, repay existing interest-bearing bank loans, and supplement working capital. CICC and Huaxing Securities International are the joint placement agents.